Substance Abuse and Cognitive Functioning in Schizophrenia

Journal of Psychiatry and Neuroscience

Volumn 22, Issue 2, 1997, Pages 99-104

  Addington, Jean ^a,b   Addington, Donald ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Cognitive functioning; Schizophrenia; Substance abuse

Indexed keywords

PSYCHOTROPIC AGENT; STREET DRUG;

ADDICTION; ADULT; ARTICLE; CANADA; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL PROBLEM; STATISTICS;

ADULT; CANADA; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; SOCIAL PROBLEMS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 0031093183     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. American Psychiatric Association. 1987. Diagnostic and statistical manual of mental disorders. 3rd ed. Revised. Washington (DC): American Psychiatric Association; 567 p.
2. Arndt S, Tyrrel G, Flaum M, Andreasen NC. 1992. Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychol Med 22:379-88.
3. Asarnow RF, Granholm E, Sherman T. 1991. Span of apprehension in schizophrenia. In: Steinhauer SR, Gruzelier JH, Zubin J, editors. Handbook of schizophrenia. Volume 5, Neuropsychology, psychophysiology and information processing. Amsterdam: Elsevier Science, p 335-70.
4. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush PW, Noordsy DL. 1993. Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis 181:227-32.
5. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. 1990. The Social Functioning Scale: the development and validation of a new scale of social adjustment for use in family intervention programs with schizophrenic patients. Br J Psychiatry 157:853-9.
6. Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S. 1991. Substance abuse and schizophrenia: effects on symptoms but not neurocognitive function. J Clin Psychiatry 52:26-30.
7. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. 1991. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148:224-30.
8. Drake RE, Osher FC, Wallach MA. 1989. Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 177:408-14.
9. Eckhardt MJ, Stapleton JM, Rawlings RR, Davis EZ, Grondin DM. 1995. Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age. Am J Psychiatry 153:53-9.
10. el-Guebaly N, Hodgins DC. 1992. Schizophrenia and substance abuse: prevalence issues. Can J Psychiatry 37:704-10.
11. Grant I. 1987. Alcohol and the brain: neuropsychological correlates. J Consult Clin Psychol 55:310-24.
12. Grant I, Reed R. 1985. Neuropsychology of alcohol and drug abuse. In: Alterman AI, editor. Substance abuse and psychopathology. New York: Plenum, p 289-341.
13. Heaton RK. 1981. The Wisconsin Card Sorting Test Manual. Odessa (FL): Psychological Assessment Resources. p 7-49.
14. Heinrichs DW, Hanlon TE, Carpenter WT. 1984. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10:388-98.
15. Hellman SG, Green MF, Kern RS, Christenson CD. 1992. Comparison of card and computer versions of the Wisconsin Card Sorting Test for psychotic patients. Int J Methods Psychiatr Res 1:151-5.
16. Jones-Gotman M, Milner B. 1977. Design fluency: the invention of nonsense drawings after frontal cortical lesions. Neuropsychologia 15:657-74.
17. Kay SR, Fizbein A, Opler LA. 1987. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261-76.
18. Lieberman JA, Jody D, Geisler S, Vital-Herne J, Alvir JMJ, Walseben J, Woerner MG. 1989. Treatment outcome of first-episode schizophrenia. Psychopharmacol Bull 25:92-6.
19. Mueser KT, Bellack AS, Blanchard JJ. 1992a. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol 60:845-56.
20. Mueser KT, Yarnod PR, Bellack AS. 1992b. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand 85:48-55.
21. Mueser KT, Yarnod PR, Levinson DF, Singh H, Bellack AS, Kee AS, Morrison RL, Yadalem K. 1990. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16:31-56.
22. Nuechterlein KH. 1991. Vigilance in schizophrenia and related disorders. In: Steinhauer SR, Gruzelier JH, Zubin J, editors. Handbook of schizophrenia. Volume 5, Neuropsychology psychophysiology and information processing. Amsterdam: Elsevier Science, p 397-433.
23. Rey A. 1942. L'examen psychologique. Archives de Psychologie 28:112-64.
24. Sevy S, Kay SR, Opler L, van Praag HM. 1990. Significance of cocaine history in schizophrenia. J Nerv Ment Dis 178:642-8.
25. Spitzer RL, Williams JB, Gibbon M, First MB. 1990. User's guide for the Structured Clinical Interview for DSM-III-R SCID Washington (DC): American Psychiatric Press.
26. Thurstone LL, Thurstone TG. 1943. The Chicago tests of primary mental abilities. Chicago: Science Research Associates.
27. Tracy JI, Josiassen R, Bellack AS. 1995. Neuropsychology of dual diagnosis: understanding the combined effects of schizophrenia and substance use disorders. Clin Psychol Rev 15:67-97.